OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 124 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $26,129,000 | +16.3% | 5,278,672 | +83.9% | 0.66% | +6.8% |
| Q1 2015 | $22,476,000 | +16.6% | 2,870,492 | -9.7% | 0.62% | +37.8% |
| Q4 2014 | $19,269,000 | -6.5% | 3,179,762 | -34.3% | 0.45% | -5.1% |
| Q3 2014 | $20,611,000 | -27.6% | 4,838,324 | +5.1% | 0.47% | -16.7% |
| Q2 2014 | $28,459,000 | -14.6% | 4,604,958 | -10.2% | 0.57% | -5.8% |
| Q1 2014 | $33,339,000 | +17.3% | 5,129,129 | +1.6% | 0.60% | +5.8% |
| Q4 2013 | $28,415,000 | +29.4% | 5,047,119 | +40.8% | 0.57% | +7.9% |
| Q3 2013 | $21,966,000 | +3.1% | 3,583,342 | -1.7% | 0.53% | +19.4% |
| Q2 2013 | $21,312,000 | +49.3% | 3,646,260 | +59.9% | 0.44% | -6.1% |
| Q1 2013 | $14,273,000 | – | 2,280,053 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |